| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.3 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.05 | 0.3 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.05 | 0.3 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.049 | 0.3 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.05 | 0.3 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |